ERMA — Enorama Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Enorama Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	SAS	—	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	4.73	12.2	4.14	6.15	2.08
Net Total Accounts Receivable
Net Total Receivables	5.99	8.41	3.42	1.5	0.842
Total Inventory
Prepaid Expenses
Total Current Assets	12.8	22.4	11.8	13	15.2
Net Property, Plant And Equipment	2.83	2.22	1.54	0.862	0.142
Net Intangible Assets
Other Long Term Assets
Total Assets	40.9	50.9	48.7	34.4	15.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.6	11.7	12.4	10.2	8.09
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	39.1	29.6	17.2	14.8	8.09
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1.78	21.4	31.5	19.5	7.8
Total Liabilities & Shareholders' Equity	40.9	50.9	48.7	34.4	15.9
Total Common Shares Outstanding